PASG 8-K 2026-11-06

Passage BIO, Inc. (PASG) 8-K dated 2026-11-06 — accession 0001140361-26-042222.

Passage BIO, Inc. (PASG) is a biotechnology company listed on US.

Passage BIO, Inc. filed a 8-K on 2026-11-06. Accession 0001140361-26-042222.

This 8-K covers: Director/officer change (Item 5.02), Shareholder vote results (Item 5.07), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for PASG is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The PASG SEC hub lists recent forms. The stock page is the research view.